 Survival Rate
"Survival Rate" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The proportion of survivors in a group, e.g., of patients, studied and followed over a period, or the proportion of persons in a specified group alive at the beginning of a time interval who survive to the end of the interval. It is often studied using life table methods.
| Descriptor ID |
D015996
|
| MeSH Number(s) |
E05.318.308.985.550.900 L01.280.975.550.900 N01.224.935.698.826 N06.850.505.400.975.550.900 N06.850.520.308.985.550.900
|
| Concept/Terms |
Survival Rate- Survival Rate
- Rate, Survival
- Rates, Survival
- Survival Rates
Mean Survival Time- Mean Survival Time
- Mean Survival Times
- Survival Time, Mean
- Survival Times, Mean
- Time, Mean Survival
- Times, Mean Survival
Cumulative Survival Rate- Cumulative Survival Rate
- Cumulative Survival Rates
- Rate, Cumulative Survival
- Rates, Cumulative Survival
- Survival Rate, Cumulative
- Survival Rates, Cumulative
|
Below are MeSH descriptors whose meaning is more general than "Survival Rate".
Below are MeSH descriptors whose meaning is more specific than "Survival Rate".
This graph shows the total number of publications written about "Survival Rate" by people in this website by year, and whether "Survival Rate" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1989 | 0 | 1 | 1 | | 1990 | 0 | 5 | 5 | | 1991 | 0 | 4 | 4 | | 1992 | 0 | 2 | 2 | | 1993 | 0 | 5 | 5 | | 1994 | 0 | 4 | 4 | | 1995 | 0 | 15 | 15 | | 1996 | 0 | 10 | 10 | | 1997 | 0 | 8 | 8 | | 1998 | 0 | 12 | 12 | | 1999 | 0 | 7 | 7 | | 2000 | 0 | 9 | 9 | | 2001 | 0 | 8 | 8 | | 2002 | 0 | 9 | 9 | | 2003 | 1 | 11 | 12 | | 2004 | 0 | 5 | 5 | | 2005 | 0 | 4 | 4 | | 2006 | 0 | 9 | 9 | | 2007 | 0 | 9 | 9 | | 2008 | 0 | 14 | 14 | | 2009 | 0 | 18 | 18 | | 2010 | 1 | 13 | 14 | | 2011 | 0 | 13 | 13 | | 2012 | 1 | 20 | 21 | | 2013 | 0 | 10 | 10 | | 2014 | 0 | 14 | 14 | | 2015 | 0 | 20 | 20 | | 2016 | 0 | 16 | 16 | | 2017 | 0 | 21 | 21 | | 2018 | 0 | 12 | 12 | | 2019 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Survival Rate" by people in Profiles.
-
Song KJ, Arndt AT. Is a Novel Nomogram Better Than TNM Staging at Predicting Survival in Siewert Type 2 Adenocarcinoma? Ann Surg Oncol. 2019 May; 26(5):1182-1183.
-
Varelas AN, Eggerstedt M, Ganti A, Tajudeen BA. Epidemiologic, prognostic, and treatment factors in sinonasal diffuse large B -cell lymphoma. Laryngoscope. 2019 06; 129(6):1259-1264.
-
Coelho TM, Fogaroli RC, Pellizzon ACA, De Castro DG, Gondim GRM, Silva MLG, Chen MJ, Ramos H. Intraoperative radiation therapy for the treatment of recurrent retroperitoneal and pelvic tumors: a single-institution analysis. Radiat Oncol. 2018 Nov 20; 13(1):224.
-
Miller C, Shay A, Tajudeen B, Sen N, Fidler M, Stenson K, Gattuso P, Al-Khudari S. Clinical features and outcomes in young adults with oral tongue cancer. Am J Otolaryngol. 2019 Jan - Feb; 40(1):93-96.
-
Jandali DB, Ganti A, Al-Khudari S, Tajudeen BA, Revenaugh PC. Prognostic factors and survival outcomes for head and neck cutaneous adnexal cancers. Am J Otolaryngol. 2019 Jan - Feb; 40(1):110-114.
-
Chew W, Benson C, Thway K, Hayes A, Miah A, Zaidi S, Lee ATJ, Messiou C, Fisher C, van der Graaf WT, Jones RL. Clinical Characteristics and efficacy of chemotherapy in sclerosing epithelioid fibrosarcoma. Med Oncol. 2018 Sep 05; 35(11):138.
-
Payne J, Garlitski AC, Weinstock J, Homoud M, Madias C, Estes NAM. His bundle pacing. J Interv Card Electrophysiol. 2018 Aug; 52(3):323-334.
-
Shammo JM, Komrokji RS. Clinical consequences of iron overload in patients with myelodysplastic syndromes: the case for iron chelation therapy. Expert Rev Hematol. 2018 07; 11(7):577-586.
-
Schnitzbauer AA, Schadde E, Linecker M, Machado MA, Adam R, Malago M, Clavien PA, de Santibanes E, Bechstein WO. Indicating ALPPS for Colorectal Liver Metastases: A Critical Analysis of Patients in the International ALPPS Registry. Surgery. 2018 09; 164(3):387-394.
-
Fidler MJ, Fhied CL, Roder J, Basu S, Sayidine S, Fughhi I, Pool M, Batus M, Bonomi P, Borgia JA. The serum-based VeriStrat® test is associated with proinflammatory reactants and clinical outcome in non-small cell lung cancer patients. BMC Cancer. 2018 03 20; 18(1):310.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|